Gujarat Kidney & Super Speciality Reports 7.02% Rise in Q2 2026 Net Profit

Gujarat Kidney & Super Speciality, a leading provider of renal and super specialty services, reported a 7.02% rise in consolidated net profit for the June 2026 quarter. The company’s earnings increased compared to the same period last year, driven by higher patient volumes and improved operational efficiency. Shares of the firm were reported to rise in early trading, reflecting investor confidence in its growth trajectory. Management highlighted plans to expand its network of specialty centers and invest in advanced diagnostic technologies to sustain momentum.